Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.
about
Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatmentImmunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Progress in immune-based therapies for type 1 diabetes.Less is more: the detrimental consequences of immunosuppressive therapy in the treatment of type-1 diabetes.
P2860
Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Anti-thymoglobulin (ATG) treat ...... ngitis virus (RIP-LCMV) model.
@en
Anti-thymoglobulin
@nl
type
label
Anti-thymoglobulin (ATG) treat ...... ngitis virus (RIP-LCMV) model.
@en
Anti-thymoglobulin
@nl
prefLabel
Anti-thymoglobulin (ATG) treat ...... ngitis virus (RIP-LCMV) model.
@en
Anti-thymoglobulin
@nl
P2860
P1476
Anti-thymoglobulin (ATG) treat ...... ngitis virus (RIP-LCMV) model.
@en
P2093
M G von Herrath
P2860
P304
P356
10.1111/J.1365-2249.2010.04304.X
P577
2011-01-14T00:00:00Z